| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407057 Ovulation triggering drugs |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046226A2 Trefoil factor 2 (tff2) peptides with moiety attached to asn15 |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | WO2002046186A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046182A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046169A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002045738A2 Vaccine composition containing transforming growth factor alpha |
| 06/13/2002 | WO2002045716A1 Use of pyrazolo[4,3-d]pyrimidines |
| 06/13/2002 | WO2001096330A3 Thrombin receptor antagonists |
| 06/13/2002 | WO2001090104A3 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 06/13/2002 | WO2001077057A3 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| 06/13/2002 | WO2001037819A3 Use of indirubine derivatives for making medicines |
| 06/13/2002 | US20020072631 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 06/13/2002 | US20020072630 Therapy |
| 06/13/2002 | US20020072614 For therapy of cardiovascular, cerebrovascular, respiratory and renal disorders |
| 06/13/2002 | US20020072534 20- Hete antagonists and agonists |
| 06/13/2002 | US20020072499 Specifically an N-formyl-methionyl-leucyl ("f-Met-Leu") tri-or tetra-peptide; pathological fibrosis or those caused by trauma or surgery |
| 06/13/2002 | US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 06/13/2002 | DE10059412A1 Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz Use of 1-phenyl-3-dimethylaminopropane compounds for the therapy of urinary incontinence |
| 06/13/2002 | DE10059411A1 Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for the therapy of urinary incontinence |
| 06/13/2002 | CA2678490A1 Isolated placental perfusate and placental cells isolated therefrom |
| 06/13/2002 | CA2436916A1 Use of pyrazolo[4,3-d]pyrimidines |
| 06/13/2002 | CA2436870A1 Substituted anthranilic acids |
| 06/13/2002 | CA2436732A1 Protein modification and maintenance molecules |
| 06/13/2002 | CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | CA2431187A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | CA2431171A1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| 06/13/2002 | CA2430989A1 Method of collecting placental stem cells |
| 06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | CA2430621A1 Vaccine composition containing transforming growth factor alpha |
| 06/13/2002 | CA2430558A1 Proteins and nucleic acids encoding same |
| 06/13/2002 | CA2430536A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | CA2430412A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | CA2430376A1 Semicarbazides and their uses as cyclin dependent kinase inhibitors |
| 06/13/2002 | CA2429641A1 Kinases and phosphatases |
| 06/13/2002 | CA2428097A1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/12/2002 | EP1213290A1 Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 06/12/2002 | EP1213281A1 Novel amide derivatives |
| 06/12/2002 | EP1212433A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212330A1 Androgen receptor modulator compounds and methods |
| 06/12/2002 | EP1212329A2 Amine derivatives of benzo[4,5]thieno[2,3-d]pyrimidine |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
| 06/12/2002 | EP1212322A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 06/12/2002 | EP1212295A1 SUBSTITUTED $g(a)-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 06/12/2002 | EP1212086A1 Immunological tolerance-induction agent |
| 06/12/2002 | EP1212077A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 06/12/2002 | EP1212067A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 06/12/2002 | EP1212062A1 Use of thienopyrimidines |
| 06/12/2002 | EP1212041A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP0859621B1 Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| 06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/12/2002 | CN1353610A Medicinal composition for oral administration |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353581A Method and composition for masking mineral taste |
| 06/12/2002 | CN1352978A Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process |
| 06/12/2002 | CN1352948A Prescription and preparing process of medicine for treating renal calculus |
| 06/12/2002 | CN1086127C Suppository for treating prostate disease |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
| 06/11/2002 | US6403611 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/11/2002 | US6403604 Nitrogen-based camptothecin derivatives |
| 06/11/2002 | US6403601 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403573 Compounds of azetidine and pyrrolidin |
| 06/11/2002 | US6403361 Enzymatic method for modification of recombinant polypeptides |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/11/2002 | CA2198578C Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 06/06/2002 | WO2002044419A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |